Search
Login
Register
Menu
BJH
Home
News
CongressUpdate
Guidelines
Specials
Links
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Guidelines
Guidelines BHS
2022
BHS guidelines on supportive care in lymphoma: Part 2
BHS guidelines on supportive care in lymphoma: Part 1
Diagnosis and treatment of peripheral T-cell lymphomas: Update recommendations of the Belgian Hematology Society (BHS)
2021
Guidelines of the Belgian Hematology Society for imaging in multiple myeloma
How to treat classical Hodgkin’s lymphoma in older patients: Belgian expert opinion
Management of polycythemia vera: Recommendations from the BHS MPN subcommittee anno 2021
Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society
Belgian guidelines for diagnosis and treatment of chronic myelomonocytic leukaemia
2020
Diagnosis and treatment of AL amyloidosis: Belgian guidelines
Practical management of multiple myeloma: Update 2020
BHS Guidelines for the Management of Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukaemia, anno 2020
BHS guidelines for the treatment of newly diagnosed diffuse large B-cell lymphoma (DLBCL) anno 2020
2019
Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma anno 2019
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the Commission Personalised Medicine
BHS guidelines for the treatment of marginal zone lymphomas: 2018 update
BHS clinical guidelines on the management of acute complications in sickle cell disease
Guidelines of the Belgian Hematology Society on the use of stem cell transplantation in lymphoproliferative diseases
2018
Hodgkin’s lymphoma: Belgian Hematology Society guidelines in diagnosis, treatment and follow-up
Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenström macroglobulinemia anno 2018
2016
BHS guidelines for the treatment of large granular lymphocyte and chronic prolymphocytic leukaemias
BHS guidelines for primary central nervous system lymphoma
Updated BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2016
2015
Diagnosis and treatment of AL Amyloidosis in 2015: Consensus guidelines of the Belgian Hematological Society
Treatment of mantle cell lymphomas: Updated recommendations of the Belgian Hematological Society 2015
Waldenström’s macroglobulinaemia: Belgian Hematology Society guidelines
BHS 2013 recommendations for treatment of myelodysplastic syndromes
BHS Guidelines for the treatment of Burkitt’s lymphoma
The 2013 Belgian Hematological Society recommendations for the diagnosis and classification of myelodysplastic syndromes
Practical management of chronic myeloid leukemia in Belgium
2014
Update on the initial therapy of multiple myeloma
Treatment of mantle cell lymphomas: recommendations of the Belgian Hematological Society
Vaccination guidelines in haematopoietic transplant patients: recommendations from the BHS Transplant Committee
BHS guidelines for the treatment of marginal zone lymphomas
2013
Disease characteristics in Belgian myelofibrosis patients and management guidelines anno 2013
Guidelines for newly diagnosed diffuse large B-cell lymphoma (DLBCL) and relapsed DLBCL
Primary immune thrombocytopenia in adults
2012
BHS guidelines for the treatment of chronic lymphocytic leukaemia anno 2012
Point of view about new guidelines on ESAs (erythropoiesis-stimulating agents)
Guidelines of the Belgian Hematological Society for newly diagnosed and relapsed follicular lymphoma 2012
2011
Use of alemtuzumab in B-cell chronic lymphocytic leukaemia: Belgian recommendations
2010
Guidelines of the Belgian Hemovigilance Report